Mirum Pharmaceuticals, Inc. MIRM Operating Lease Liabilities (Total)

Operating Lease Liabilities (Total) at other companies

LQD

Liquidia CorporationLQDA

$6.96M+1.5%

BridgeBio PharmaBBIO

$18.66M+84.3%

Arrowhead ResearchARWR

$107.88M-5.6%

Zevra Therapeutics, Inc.ZVRA

$1.5M-5.6%

Aurinia PharmaceuticalsAUPH

$3.71M-41.8%

Cumberland PharmaceuticalsCPIX

$4.71M-7.6%

FAQ

What is Mirum Pharmaceuticals, Inc.'s operating lease liabilities (total)?

Mirum Pharmaceuticals, Inc. (MIRM) reported operating lease liabilities (total) of $12.87M in Q2 2026.

How has Mirum Pharmaceuticals, Inc.'s operating lease liabilities (total) changed year-over-year?

Mirum Pharmaceuticals, Inc.'s operating lease liabilities (total) increased by 29.2% year-over-year, from $9.97M to $12.87M.

What is the long-term trend for Mirum Pharmaceuticals, Inc.'s operating lease liabilities (total)?

Over 5 years (2020 to 2025), Mirum Pharmaceuticals, Inc.'s operating lease liabilities (total) has grown at a 24.2% compound annual growth rate (CAGR), from $3.26M to $9.66M.

What does operating lease liabilities (total) mean?

This represents the total present value of future lease payments for operating leases, recognized as a liability on the balance sheet. It reflects the company's long-term commitment to leased assets such as office space, warehouses, and equipment. Tracking this helps investors evaluate the company's off-balance-sheet financing obligations and overall debt-like commitments.